DUTASTERIDE TEVA 0,5 mg, capsule molle — plaquette(s) PVC PVDC aluminium de 30 capsule(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930091241
  • CIP7 3009124
  • CIS 61743794

What the source publishes

Holder
TEVA SANTE
Active ingredients
DUTASTÉRIDE
Form
capsule molle
Package
plaquette(s) PVC PVDC aluminium de 30 capsule(s)
Routes
orale
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration de commercialisation
Authorised on
2017-04-28
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930091241
{
  "cis": "61743794",
  "cip7": "3009124",
  "form": "capsule molle",
  "name": "DUTASTERIDE TEVA 0,5 mg, capsule molle — plaquette(s) PVC PVDC aluminium de 30 capsule(s)",
  "cip13": "3400930091241",
  "holder": "TEVA SANTE",
  "routes": [
    "orale"
  ],
  "holders": [
    "TEVA SANTE"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "8.25",
  "authorisedOn": "2017-04-28",
  "compositions": [
    {
      "name": "DUTASTÉRIDE",
      "nature": "SA",
      "strength": "0,5 mg",
      "linkageNumber": "1",
      "substanceCode": "36065",
      "dosageReference": "une capsule",
      "pharmaceuticalElement": "capsule"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "7.23",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "DUTASTERIDE TEVA 0,5 mg, capsule molle",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) PVC PVDC aluminium de 30 capsule(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "30%"
  ],
  "marketingDeclaredOn": "2017-07-28",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "DUTASTÉRIDE"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": "Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Hypertrophie bénigne de la prostate, en seconde intention, après échec de certains autres traitements :<br>. traitement des symptômes modérés à sévères<br>. prévention des risques associés (rétention aiguë d'urine, chirurgie) ; JOURNAL OFFICIEL ; 22/02/13",
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930091241"